Supraphysiological doses of anabolic steroids and the effects on the heart of sedentary young rats: a morphometric study
DOI:
https://doi.org/10.33448/rsd-v9i11.10079Keywords:
Heart; Heart ventricles; Anabolic agents; Steroids; Rats.Abstract
The main objective of study was to observe the effects of certain anabolic androgenic steroids on sedentary young rats hearts. For this, an experimental study was carried out using Wistar lineage rats (n = 20). The treatment consisted in application of two anabolics steroids, nandrolone decanoate (DN) and a combination of testosterone propionate, testosterone phenpropionate, testosterone isocaproate and testosterone decanoate (TS). The animals were divided into four groups, containing five animals each: GI- control, Group II called the DECA group (DN), Group III, named DURA group (TS) and Group IV called the DURA + DECA group (DN + TS). The treatment lasted thirty days and the doses were made available once a week. After euthanasia, the hearts were removed and submitted to morphometric analysis. Using specific software, the ventricular lumen and the left ventricular muscle wall were measured. Statistical analysis was performed through analysis of variance followed by Tukey's means comparison test. From results obtained, it is concluded that use of these drugs in pre-established dose and treatment period in this experiment did not cause significant cardiac changes. However, it is important to note that these results do not guarantee that the use of these steroids, in doses used, are safe.
References
Agis-Balboa, R. C., Pibiri, F., Nelson, M., & Pinna, G. (2009). Enhanced fear responses in mice treated with anabolic androgenic steroids. Neuroreport, 20(6), 617.
Cunha, T. S., Cunha, N. S., Moura, M. J. C. S., & Marcondes, F. K. (2004). Esteróides anabólicos androgênicos e sua relação com a prática desportiva. Revista Brasileira de Ciências Farmacêuticas, 40(2), 165-179.
de Ronde, W., & Smit, D. L. (2020). Anabolic androgenic steroid abuse in young males. Endocrine Connections, 9(4), R102-R111.
Fleck, S. J., Pattany, P. M., Stone, M. H., Kraemer, W. J., Thrush, J., & Wong, K. (1993). Magnetic resonance imaging determination of left ventricular mass: junior Olympic weightlifters. Medicine and science in sports and exercise, 25(4), 522–527.
Goldwire, M. A., & Price, K. O. (1995). Sports pharmacy: counseling athletes about banned drugs. American pharmacy, NS35(5), 24–30.
Guimarães Neto, W. (2002). Musculação. Guarulhos: Phorte.
Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports medicine (Auckland, N.Z.), 34(8), 513–554. https://doi.org/10.2165/00007256-200434080-00003
Haupt, H. A., & Rovere, G. D. (1984). Anabolic steroids: a review of the literature. The American journal of sports medicine, 12(6), 469–484. https://doi.org/10.1177/0 36354658401200613
Kicman A. T. (2008). Pharmacology of anabolic steroids. British journal of pharmacology, 154(3), 502–521. https://doi.org/10.1038/bjp.2008.165
Karila, T. A., Karjalainen, J. E., Mäntysaari, M. J., Viitasalo, M. T., & Seppälä, T. A. (2003). Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone. International journal of sports medicine, 24(5), 337–343. https://doi.org/10.1055/s-2003-40702
Kennedy M. C. (1992). Anabolic steroid abuse and toxicology. Australian and New Zealand journal of medicine, 22(4), 374–381. https://doi.org/10.1111/j.1445-5994.1992.tb02151.x
Kennedy M. C. (2000). Newer drugs used to enhance sporting performance. The Medical journal of Australia, 173(6), 314–317.
Luke, J. L., Farb, A., Virmani, R., & Sample, R. B. (1990). Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. Journal of Forensic Science, 35(6), 1441-1447.
Machado, N. H. S., Socorro, M., Marinho, N., Pinheiro, N. V., Silva, P. R. R., Melo, R. F., & Leme, V. L. (2003). Esteróides anabolizantes: efeitos anabólicos e andrógenos. Cienc Farmaceut, 1, 1-4.
Nieminen, M. S., Rämö, M. P., Viitasalo, M., Heikkilä, P., Karjalainen, J., Mäntysaari, M., & Heikkilä, J. (1996). Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. European heart journal, 17(10), 1576–1583. https://doi.org/10.1093/oxfordjournals.eurheartj.a014724
Oigman, W., & Neves, M. F. T. (2000). Sistema renina-angiotensina e hipertrofia ventricular esquerda. Rev Bras Hipertens, 3, 261-7.
Payne, J. R., Kotwinski, P. J., & Montgomery, H. E. (2004). Cardiac effects of anabolic steroids. Heart (British Cardiac Society), 90(5), 473–475. https://doi.org/10.1136/hrt.2003.025783
Peluso, M. A. M., Assunção, S. S. M., Araujo, L. A. S. B. D., & Andrade, L. H. S. G. D. (2000). Alterações psiquiátricas associadas ao uso de anabolizantes. Rev. psiquiatr. clín.(São Paulo), 229-36.
Robergs, R.A.; Robergs, S.O. (2002) Princípios fundamentais de fisiologia do exercício para aptidão, desempenho e saúde (1a ed). São Paulo: Editora Phorte.
Sachtleben, T. R., Berg, K. E., Elias, B. A., Cheatham, J. P., Felix, G. L., & Hofschire, P. J. (1993). The effects of anabolic steroids on myocardial structure and cardiovascular fitness. Medicine and science in sports and exercise, 25(11), 1240–1245.ur
Seara, F., Barbosa, R., de Oliveira, D. F., Gran da Silva, D., Carvalho, A. B., Freitas Ferreira, A. C., Matheus Nascimento, J. H., & Olivares, E. L. (2017). Administration of anabolic steroid during adolescence induces long-term cardiac hypertrophy and increases susceptibility to ischemia/reperfusion injury in adult Wistar rats. The Journal of steroid biochemistry and molecular biology, 171, 34–42. https://doi.org/10.1016/j.jsbmb.2017.01.012
Seara, F., Pereira-Junior, P. P., Silva-Almeida, C., Dos-Santos, R. C., Souza, R. N., Costa, C., Domingos, A. E., Barbosa, R., Ferraz, A. P., Machado, A., Ceccato, V. M., Takiya, C. M., Ponte, C. G., Reis, L. C., Olivares, E. L., & Nascimento, J. (2020). Anabolic steroid excess promotes hydroelectrolytic and autonomic imbalance in adult male rats: Is it enough to alter blood pressure? Steroids, 163, 108711. https://doi.org/10.1016/j.steroids.2020.108711
Silva, G. G., de Freitas Brito, A., de S Nogueira, F. R., Júnior, F. C., Galan Ribeiro, S. L., de Oliveira, C. V. C., & dos Santos, M. A. P. (2017). Prevalência do uso de esteroides anabólicos androgênicos em praticantes de musculação de Teresina-PI. Revista Portuguesa de Ciências do Desporto.
Silva, P. R. P. D., Danielski, R., & Czepielewski, M. A. (2002). Esteróides anabolizantes no esporte. Revista Brasileira de Medicina do Esporte, 8(6), 235-243.
Su, T. P., Pagliaro, M., Schmidt, P. J., Pickar, D., Wolkowitz, O., & Rubinow, D. R. (1993). Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA, 269(21), 2760–2764.
Sullivan, M. L., Martinez, C. M., Gennis, P., & Gallagher, E. J. (1998). The cardiac toxicity of anabolic steroids. Progress in cardiovascular diseases, 41(1), 1–15. https://doi.org/10.1016/s0033-0620(98)80019-4
Takala, T. E., Kiviluoma, K., Kihlström, M., Rämö, P., & Vihko, V. (1992). Effects of physical training, methandione and their combination on the lysosomal hydrolytic activities in dog heart. International journal of sports medicine, 13(1), 52–55. https://doi.org/10.1055/s-2007-1021234
Thein, L. A., Thein, J. M., & Landry, G. L. (1995). Ergogenic aids. Physical therapy, 75(5), 426–439. https://doi.org/10.1093/ptj/75.5.426
Urhausen, A., Hölpes, R., & Kindermann, W. (1989). One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. European journal of applied physiology and occupational physiology, 58(6), 633–640. https://doi.org/10.1007/BF00418510
Urhausen, A., Albers, T., & Kindermann, W. (2004). Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart (British Cardiac Society), 90(5), 496–501. https://doi.org/10.1136/hrt.2003.015719
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Cayque Alves Sobrinho; Wagner Costa Rossi Junior; Wagner Corsini; Evelise Aline Soares; Alessandra Esteves
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
